supp.fit

Calcium, Zinc and Vitamin D: study protocols

13 study groups took Calcium together with Zinc and Vitamin D. These are the doses the studies gave. They are not a recommendation.

Calcium: what the research found →

Dose per serving from research: Calcium

13 study groups in 11 studies say how much Calcium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 54% of 13 study groups.

Daily doseStudy groups
250 mg or less
1
250 mg to 500 mg
2
500 mg to 1 g
7
1 g to 2.5 g
3

Dose per serving from research: Zinc

13 study groups in 11 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg, 46% of 13 study groups.

Daily doseStudy groups
1 mg to 2.5 mg
3
2.5 mg to 5 mg
0
5 mg to 10 mg
6
10 mg to 25 mg
3
over 25 mg
1

Dose per serving from research: Vitamin D

5 study groups in 5 studies say how much Vitamin D participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 IU to 500 IU, 80% of 5 study groups.

Daily doseStudy groups
250 IU to 500 IU
4
500 IU to 1,000 IU
0
1,000 IU to 2,500 IU
0
over 2,500 IU
1

Commonly used together

13 of 13 study groups took Calcium, Zinc and Vitamin D with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Magnesium
7
Iron
4
Vitamin B12
4

13 study groups

Study
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Intervention group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 g7 mg—1 year71
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Control group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 g7 mg—1 year69
Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
2018 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS); age not reported
800 mg8 mg400 IU12 weeks30
A prospective randomized comparative trial evaluating postoperative nutritional intervention in patients with oral cancer
2022 · Intervention group · Adults with oral cancer after surgery; ages 18 and older, both sexes
1 g40 mg2,857 IU26 weeks22
School-based calcium-vitamin D with micronutrient supplementation enhances bone mass in underprivileged Indian premenarchal girls
2012 · Ca+MZ-group · Premenarchal girls aged 8–12 years from low-income groups in Pune, India
500 mg15 mg—1 year—
Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
2014 · Ca+MZn+D group (C1) · Underprivileged premenarchal girls aged 8–12 years
500 mg15 mg—1 year—
[Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial]
2004 · Group 1: Vitrum Osteomag · Postmenopausal women with osteopenia; age range not reported
1.2 g15 mg400 IU1 year125
Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year
2018 · intervention · Chinese postmenopausal women in Malaysia; mean age 59 years
1.2 g2.4 mg15 mcg1 year61
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
150 mg10 mg10 mcg—870
A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome
2017 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS)
800 mg8 mg400 IU12 weeks30
The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes
2019 · Magnesium-zinc-calcium-vitamin D group · Women aged 18–40 with gestational diabetes mellitus, at 24–28 weeks’ gestation at diagnosis
800 mg8 mg400 IU6 weeks30
Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women
2016 · Intervention (Int), premenopausal women · Premenopausal women, mean age 41 years; no specific condition stated
1 g2.4 mg15 mcg12 weeks—
Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women
2016 · Intervention (Int), postmenopausal women · Postmenopausal women, mean age 59 years; no specific condition stated
1.2 g2.4 mg15 mcg12 weeks—
Calcium, Zinc and Vitamin D: study protocols | supp.fit